In a groundbreaking systematic review published in BMC Cancer, researchers unveil compelling evidence supporting the role of omega-3 fatty acids in enhancing immune function and improving clinical outcomes among surgical gastric cancer patients. This meta-analysis, encompassing data from over two thousand patients across thirty-two randomized controlled trials, adds a significant layer of insight into nutritional interventions that may mitigate postoperative complications, a prevalent concern in this vulnerable patient population.
Gastric cancer remains a leading cause of cancer-related mortality worldwide, often complicated by postoperative infections and immune dysfunction. The intricate balance of immune cells plays a pivotal role in patient recovery following surgery. Among these, CD4+ and CD8+ T lymphocytes orchestrate immune responses critical to combating infections and facilitating tissue repair. Understanding interventions that modulate these immune parameters has therefore become a focus of intense research.
Omega-3 fatty acids, predominantly found in fish oils, have long been recognized for their anti-inflammatory properties and immunomodulatory effects. However, their specific impact in the context of surgical oncology, particularly gastric cancer, had remained ambiguous until now. This systematic review rigorously synthesizes evidence derived from seven leading databases, including the Cochrane Library and PubMed, ensuring comprehensive coverage of relevant randomized controlled trials (RCTs).
The researchers employed meticulous methodologies, including the Revised Cochrane risk-of-bias tool and trial sequential analysis, to ascertain the robustness and reliability of their findings. Such statistical rigor minimizes the likelihood of spurious associations, a common pitfall in meta-analyses. The trial sequential analysis, in particular, confirmed that the accumulated data reached the required information size, thus validating the primary outcomes.
One of the most striking findings detailed in the review is the substantial reduction in infectious complications among patients receiving omega-3 fatty acid supplementation. Relative risk analysis indicates that those supplemented had less than half the risk of infections post-surgery compared to controls. Given that infections significantly contribute to morbidity and prolonged hospitalization, this finding could herald a paradigm shift in perioperative nutritional management.
In addition to lowering infection rates, omega-3 fatty acids were shown to meaningfully reduce the length of hospital stay by an average of over one day. This decrease translates not only into cost-savings for healthcare systems but also reflects improved clinical trajectories and faster recovery times for patients—a dual benefit of high clinical relevance.
From an immunological perspective, the meta-analysis highlights notable enhancements in CD4+ T cell levels following omega-3 intervention. The CD4+ subset, crucial for orchestrating adaptive immune responses, showed statistically significant elevation, implying a restored or enhanced immune competence among supplemented patients. Conversely, no significant changes were observed regarding in-hospital mortality, suggesting that while omega-3 improves aspects of immune function and recovery, it does not necessarily influence immediate survival outcomes.
The heterogeneity of results, as indicated by I² statistics, was minimal concerning infectious complications, reinforcing the consistency of the benefits across diverse study populations and protocols. However, higher heterogeneity seen in outcomes like hospital stay length warrants cautious interpretation and signals avenues for further research to delineate contributing factors.
Beyond clinical parameters, the nutritional modulation of T cell subsets—CD4+, CD8+, and their ratios—underscores the potential mechanistic pathways by which omega-3 fatty acids exert immune regulatory effects. Enhancing these immune cell populations could reduce susceptibility to postoperative infections, a frequent and serious complication in gastric cancer surgeries.
This comprehensive analysis also employed GRADE assessments to rate the certainty of evidence, rating outcomes related to immune parameters and infectious complications with moderate confidence. Outcomes like hospital stay length and mortality were rated lower in certainty, indicating the need for more nuanced studies targeting these particular endpoints.
The trial registration through PROSPERO adds transparency and methodological rigor, ensuring that this meta-analysis adheres to predefined protocols and reduces bias. This adherence strengthens confidence in the findings’ validity and their potential translation into clinical guidelines.
Clinicians and surgeons confronting the challenges of managing gastric cancer patients may now consider omega-3 fatty acid supplementation as a viable adjunctive therapy to bolster immune defenses and potentially streamline recovery. This is of particular importance given the limited pharmacological options that directly address immune dysfunction in the perioperative setting.
However, the review’s authors caution that while omega-3 fatty acids demonstrated promising outcomes, the low certainty on mortality and hospital stay reduction underscores the complexity of perioperative care and the multifactorial nature of recovery and survival. They call for further high-quality RCTs to refine dosing strategies, timing, and patient selection criteria.
This evolution in understanding aligns with a broader trend in oncology towards integrating nutritional and immunological therapies to improve patient outcomes. Omega-3 fatty acids, as accessible and generally safe supplements, could represent a cornerstone in multimodal care strategies that transcend traditional chemotherapy and surgical interventions.
Future research directions include exploring the molecular immunological pathways modulated by omega-3 fatty acids, such as alterations in cytokine profiles, resolution of inflammation, and tumor microenvironment dynamics. Additionally, assessing long-term effects on survival, quality of life, and recurrence rates will be essential to fully establish the clinical utility of such interventions.
In summary, this comprehensive meta-analysis sheds light on the promising role of omega-3 fatty acid supplementation in reducing infectious complications and enhancing immune cell function in gastric cancer patients undergoing surgery. While not definitively affecting mortality, these findings open new avenues for improving perioperative care through targeted nutritional strategies, marking a significant advance in surgical oncology supportive care.
Subject of Research: Impact of omega-3 fatty acids on immune functions and clinical outcomes in surgical gastric cancer patients.
Article Title: Impacts of omega-3 fatty acids intervention on immune functions and clinical outcomes in surgical gastric cancer patients: a systematic review and trial sequential meta-analysis.
Article References:
Yue, H.Y., Yang, X.T., Zhang, J.C. et al. Impacts of omega-3 fatty acids intervention on immune functions and clinical outcomes in surgical gastric cancer patients: a systematic review and trial sequential meta-analysis. BMC Cancer 25, 1366 (2025). https://doi.org/10.1186/s12885-025-14788-4
Image Credits: Scienmag.com
